Details
Description
Inclusion Criteria
Exclusion Criteria
Details
Title A Phase III Study Comparing Single-Agent Olaparib or the Combination of Cediranib and Olaparib to Standard Platinum-Based Chemotherapy in Women with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
IRB NRG-GY004
CC 16-360
Hospital Fairview, Hillcrest, Main Campus
Phase Phase 3
Disease Fallopian Tube, Gynecologic, Ovarian, Peritoneal
Drug Cediranib, Olaparib